WHWK
Whitehawk Therapeutics, Inc.
3.70$
-3.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.2% | -16.1% | -8.5% | -15.7% | -17.9% | +232.8% | -22.7% | -7.6% | -9.7% | -15.6% | +52.5% | |
| – | -6.2% | -17.7% | -9.3% | -16.9% | -20.7% | +279.5% | -23.2% | -7.6% | -9.7% | -15.7% | +53.3% | |
| – | -8.6% | -14.5% | -23.5% | -25.8% | -6.1% | +693.8% | -36.3% | -73.8% | -1.0% | -7.4% | +145.0% | |
| – | -8.8% | -18.9% | -11.0% | -20.3% | -24.6% | +389.2% | -23.3% | -8.2% | -10.4% | -15.5% | +54.4% | |
| – | -4.0% | -10.1% | +20.0% | +10.5% | -9.7% | -100.0% | – | – | – | – | – | |
| – | +77.8% | -7.6% | +2.7% | -10.3% | -2.9% | -100.0% | – | – | – | – | – | |
| – | +26.9% | -24.3% | +10.8% | -26.3% | +6.0% | -31.2% | -28.7% | +12.5% | +47.4% | -23.9% | +0.1% | |
| – | +28.6% | -24.7% | +11.4% | -28.6% | +8.0% | -28.1% | -28.7% | +12.5% | +47.4% | -23.9% | +0.1% | |
| – | +2.6% | -2.1% | -12.0% | -13.9% | -16.8% | – | – | – | – | – | – | |
| – | +126.4% | -47.5% | -26.8% | -39.3% | +57.1% | +69.4% | -8.7% | -51.1% | -43.8% | +90.3% | -36.7% | |
| – | -11.0% | -14.0% | -12.9% | -12.6% | -23.8% | +322.5% | -22.4% | -8.7% | -13.3% | -14.8% | +57.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.1% | +0.1% | +0.1% | +0.2% | +0.0% | +155.0% | +0.2% | +0.0% | +0.0% | +19.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.